Trials / Completed
CompletedNCT00828425
Management of Diabetes Mellitus Patients With Retinopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed: * which medication are used to keep blood pressure under control? * which medication are used for metabolic control? * the average control level of metabolism and blood pressure is compliant with the international guidelines? * laser photocoagulation plays a role in the control of metabolism and blood pressure? * there are differences in the control of metabolism and blood pressure between patients with DM I or DM II? * there is an influence of renal failure on the choose of medication?
Conditions
Timeline
- Start date
- 2008-12-01
- Completion
- 2009-08-01
- First posted
- 2009-01-26
- Last updated
- 2010-08-18
Locations
62 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00828425. Inclusion in this directory is not an endorsement.